INTRODUCTION {#s1}
============

Upper aerodigestive tract cancers (UATC), encompassing the oral cavity, pharynx, larynx, salivary glands and esophagus, represent a significant cancer burden; collectively ranking fourth for cancer incidence and second for cancer mortality worldwide \[[@R1]\]. Smoking and excessive alcohol drinking are the two prominent risk factors for UATC \[[@R2]--[@R6]\]. In addition, a probable role of dietary exposure has been reported \[[@R7]--[@R9]\]; with non-starchy vegetables, and fruits having a protective role, and excess drinking, intake of red meat, and processed meat having a carcinogenic role \[[@R10]\]. Current evidence also indicates that diet plays a role in regulating inflammatory processes \[[@R11]\] by modulating the levels of inflammatory cytokines such as c-reactive protein (CRP), interleukin (IL)-6 and tumor necrosis factor (TNF)-α \[[@R12]--[@R14]\]. These components are associated with insulin resistance, adiposity, metabolic syndrome, and cardiovascular disease, and they have been shown to increase UATC risk by promoting proliferation, angiogenesis, and other mechanisms of carcinogenesis \[[@R15]--[@R24]\].

The literature-derived dietary inflammatory index (DII^®^) was developed to measure the inflammatory potential of diet in relation to six inflammatory markers \[[@R25]\], including CRP \[[@R14]\], and IL-6 \[[@R26]\]. The DII has been associated with various neoplasms including esophageal \[[@R27]\], laryngeal \[[@R28]\], pharyngeal \[[@R29]\], colorectal \[[@R30]\], prostate \[[@R31]\], pancreatic \[[@R32]\], endometrial \[[@R33]\], and hepatocellular cancers \[[@R34]\]. Most DII research has been conducted primarily in European and European-American populations \[[@R35], [@R36]\]. In contrast, among Asians, including Japanese, epidemiologic evidence about the association between inflammatory potential of diet and cancer risk is sparse. Therefore, we investigated the association between inflammatory potential of dietary intake and UATC risk with in relation to DII scores among Japanese adults.

Our objective in this study was to examine whether more pro-inflammatory diets, as measured by DII, are associated with a higher risk of UATC and if there is an interaction between DII scores and potential effect modifiers.

RESULTS {#s2}
=======

Table [1](#T1){ref-type="table"} presents baseline characteristics of the cases and controls. Smoking, alcohol consumption, flushing phenotype, number of teeth, and occupation group were statistically significantly different between cases and controls in all UATC analysis. These differences also were observed in both head and neck cancer and esophagus cancers when analyzed separately. Smoking and alcohol consumption were more prevalent among cases compared with controls, and there were more blue-collar workers than white collar workers among cases. Absence of flushing after drinking and fewer teeth were more prevalent in cases. In further analyses, these variables were considered confounders.

###### Baseline characteristics of study subjects

                             Head and neck + Esophagus                  Head and neck                             Esophagus                                                                                   
  -------------------------- --------------------------- -------------- --------------- ------------------------- ------------ -------------- --------- ------------------------- ------------ -------------- ---------
  **All male + female)**     1028                        3081           0.83            **All (male + female)**   595          1,785          0.87      **All (male + female)**   433          1,296          0.89
  male                       826 (80.4)                  2,466 (80.0)                   male                      450 (75.6)   1,344 (75.3)             male                      376 (86.8)   1,122 (86.6)   
  female                     202 (19.7)                  615 (20.0)                     female                    145 (24.4)   441 (24.7)               female                    57 (13.2)    174 (13.4)     
  **Age (mean, SD)**         (60, 10.9)                  (60, 10.8)     0.73            **Age (mean, SD)**        (60, 10.9)   (60, 10.8)     0.99      **Age (mean, SD)**        (60,10.9)    (60, 10.8)     0.62
  \<40                       56 (5.5)                    171 (5.6)                      \<40                      53 (8.9)     164 (9.2)                \<40                      3 (0.7)      7 (0.5)        
  40-49                      89 (8.7)                    276 (9.0)                      40-49                     69 (11.6)    209 (11.7)               40-49                     20 (4.6)     67 (5.2)       
  50-59                      306 (29.8)                  907 (29.4)                     50-59                     173 (29.1)   514 (28.8)               50-59                     133 (30.7)   393 (30.3)     
  60-69                      364 (35.4)                  1,144 (37.1)                   60-69                     184 (30.9)   565 (31.7)               60-69                     180 (41.6)   579 (44.7)     
  ≥70                        213 (20.7)                  583 (18.9)                     ≥70                       116 (19.5)   333 (18.7)               ≥70                       97 (22.4)    250 (19.3)     
  **Smoking**                                                           \<0.001         **Smoking**                                           \<0.001   **Smoking**                                           \<0.001
  Non                        201 (19.6)                  1,135 (36.8)                   Non                       152 (25.6)   697 (39.1)               Non                       49 (11.3)    438 (33.8)     
  Low-Modarate               122 (11.9)                  548 (17.8)                     Low-Modarate              84 (14.1)    345 (19.3)               Low-Modarate              38 (8.8)     203 (15.7)     
  High-Moderate              276 (26.9)                  636 (20.6)                     High-Moderate             144 (24.2)   344 (19.3)               High-Moderate             132 (30.5)   292 (22.5)     
  Heavy                      413 (40.2)                  730 (23.7)                     Heavy                     204 (34.3)   385 (21.6)               Heavy                     209 (48.3)   345 (26.6)     
  Unknown                    16 (1.6)                    32 (1.0)                       Unknown                   11 (1.9)     14 (0.8)                 Unknown                   5 (1.2)      18 (1.4)       
  **Alcohol consumption**                                               \<0.001         **Alcohol consumption**                               \<0.001   **Alcohol consumption**                               
  Non                        199 (19.4)                  1,019 (33.1)                   Non                       159 (26.7)   638 (35.7)               Non                       40 (9.2)     381 (29.4)     
  Moderate                   176 (17.1)                  848 (27.5)                     Moderate                  121 (20.3)   475 (26.6)               Moderate                  55 (12.7)    373 (28.8)     
  1-2 go×5/week              229 (22.3)                  711 (23.1)                     1-2 go×5/week             123 (20.7)   392 (22.0)               1-2 go×5/week             106 (24.5)   319 (24.6)     
  \>1-2 go×5/week            401 (39.0)                  467 (15.2)                     \>1-2 go×5/week           175 (29.4)   264 (14.8)               \>1-2 go×5/week           226 (52.2)   203 (15.7)     
  Unknown                    23 (2.2)                    36 (1.2)                       Unknown                   17 (2.9)     16 (0.9)                 Unknown                   6 (1.4)      20 (1.5)       
  **Flushing phenotype**                                                \<0.001         **Flushing phenotype**                                \<0.001   **Flushing phenotype**                                
  Yes                        443 (43.1)                  1,555 (59.5)                   Yes                       263 (44.2)   900 (50.4)               Yes                       180 (41.6)   655 (50.5)     
  No                         544 (52.9)                  1,455 (47.2)                   No                        302 (50.8)   843 (47.2)               No                        242 (55.9)   612 (47.2)     
  Unknown                    41 (4.0)                    71 (2.3)                       Unknown                   30 (5.0)     42 (2.4)                 Unknown                   11 (2.5)     29 (2.2)       
  Teeth                                                                 \<0.001         Teeth                                                 \<0.001   Teeth                                                 \<0.001
  0                          79 (7.7)                    121 (3.9)                      0                         43 (7.2)     78 (4.4)                 0                         79 (7.7)     121 (3.9)      
  1-8                        199 (19.4)                  374 (12.1)                     1-8                       111 (18.7)   193 (10.8)               1-8                       199 (19.4)   374 (12.1)     
  9-20                       309 (30.1)                  879 (28.5)                     9-20                      168 (28.2)   499 (28.0)               9-20                      309 (30.1)   879 (28.5)     
  ≥21                        427 (41.5)                  1,673 (54.3)                   ≥21                       264 (44.4)   991 (55.5)               ≥21                       427 (41.5)   1,673 (54.3)   
  Unknown                    14 (1.4)                    34 (1.1)                       Unknown                   9 (1.5)      24 (1.3)                 Unknown                   14 (1.4)     34 (1.1)       
  **Occupation group**                                                  \<0.001         **Occupation group**                                  \<0.001   **Occupation group**                                  \<0.001
  Blue collar                381 (37.1)                  841 (27.3)                     Blue collar               221 (37.1)   512 (28.7)               Blue collar               160 (37.0)   329 (25.4)     
  White collar               217 (21.1)                  917 (29.8)                     White collar              131 (22.0)   529 (29.6)               White collar              86 (19.9)    388 (29.9)     
  Other                      417 (40.6)                  1,272 (41.3)                   Other                     235 (39.5)   719 (40.3)               Other                     182 (42.0)   553 (42.7)     
  Unknown                    13 (1.3)                    51 (1.7)                       Unknown                   8 (1.3)      25 (1.4)                 Unknown                   5 (1.2)      26 (2.0)       
  **Subsite**                                                           1.00            Subsite                                                         Subsite                                               
  **Head and neck cancer**                                                                                                                                                                                    
  Oral cavity                255 (24.8)                  762 (24.7)                                                                                                                                           
  Nasopharynx                50 (4.9)                    153 (5.0)                                                                                                                                            
  Oropharynx                 72 (7.0)                    214 (7.0)                                                                                                                                            
  Hypopharynx                80 (7.8)                    240 (7.8)                                                                                                                                            
  Larynx                     92 (9.0)                    275 (8.9)                                                                                                                                            
  Salivary gland             23 (2.2)                    72 (2.3)                                                                                                                                             
  Other HNC                  23 (2.2)                    69 (2.2)                                                                                                                                             
  **Esophagus**              433 (42.1)                  1,296 (42.1)                                                                                                                                         

Table [2](#T2){ref-type="table"} presents the distribution of characteristics across quartiles of DII. DII scores, which ranged from --4.31 (most anti-inflammatory) to +2.02 (most pro-inflammatory). We observed a statistically significant association between DII quartiles and smoking, alcohol and occupational group, but not flushing phenotype and number of teeth. Participants with higher DII scores tended to be male, younger, heavier smokers or drinkers, and blue-collar workers, compared to subjects with lower DII scores. [Supplementary Table 2](#SD1){ref-type="supplementary-material"} presents the distribution of macro-and micro-nutrients and major food groups across DII quartiles among controls. All the nutrients showed statistically significant associations acorss DII quartiles. Carbohydrate showed a positive association with DII scores, while the others showed negative correlation. Food groups such as meat, fish, seafoods other than fish, green-yellow vegetables, other vegetables, fruits and soy also had statistically significant associations with DII quartiles and showed negative correlation with DII scores.

###### DII distribution according to confounders among controls

  Controls                  DII quartiles (%)                                          
  ------------------------- ------------------- ------------ ------------ ------------ ---------
  **Sex**                                                                              \<0.001
   Male                     538 (21.8)          607 (24.6)   628 (25.5)   693 (28.1)   
   Female                   233 (37.9)          163 (26.5)   142 (23.1)   77 (12.5)    
  **Age**                                                                              \<0.001
   \<40                     30 (17.5)           34 (19.9)    37 (21.6)    70 (40.9)    
   40--49                   54 (19.6)           57 (20.7)    84 (30.4)    81 (29.4)    
   50--59                   180 (19.9)          221 (24.4)   262 (28.9)   244 (26.9)   
   60--69                   317 (27.7)          295 (25.8)   261 (22.8)   271 (23.7)   
   70-                      190 (32.6)          163 (28.0)   126 (21.6)   104 (17.8)   
  **Smoking**                                                                          \<0.001
   Non                      378 (33.3)          279 (24.6)   254 (22.4)   224 (19.7)   
   Low-Modarate             114 (20.80)         141 (25.7)   147 (26.8)   146 (26.6)   
   High-Moderate            137 (21.5)          169 (26.6)   163 (25.6)   167 (26.3)   
   Heavy                    140 (19.2)          172 (23.6)   197 (27.0)   221 (30.3)   
   Unknown                  2 (6.3)             9 (28.1)     9 (28.1)     12 (37.5)    
  **Alcohol consumption**                                                              0.02
   Non                      269 (26.4)          259 (25.4)   244 (24.0)   247 (24.2)   
   Moderate                 219 (25.8)          196 (23.1)   207 (24.4)   226 (26.7)   
   1-2 go×5/week            191 (26.9)          185 (26.0)   171 (24.1)   164 (23.1)   
   \>2 go×5/week            83 (17.8)           119 (25.5)   137 (29.3)   128 (27.4)   
   Unknown                  9 (25.0)            11 (30.6)    11 (30.6)    5 (13.9)     
  **Flushing phenotype**                                                               0.19
   Yes                      383 (24.6)          383(24.6)    377 (24.2)   412 (26.5)   
   No                       363 (25.0)          368 (25.3)   378 (26.0)   346 (23.8)   
   Unknown                  25 (35.2)           19 (26.8)    15 (21.1)    12 (16.9)    
  **Teeth**                                                                            0.62
   0                        28 (23.1)           33 (27.3)    30 (24.8)    30 (24.8)    
   1-8                      93 (24.9)           98 (26.2)    81 (21.7)    102 (27.3)   
   9-20                     218 (24.8)          208 (23.7)   231 (26.3)   222 (25.3)   
   ≥21                      424 (25.3)          427 (25.5)   419 (25.0)   403 (24.1)   
   Unknown                  8 (23.5)            4 (11.8)     9 (26.5)     13 (38.2)    
  **Occupation group**                                                                 \<0.001
   Blue collar              143 (17.0)          191 (22.7)   230 (27.4)   277 (32.9)   
   White collar             198 (21.6)          241 (26.3)   234 (25.5)   244 (26.6)   
   Other                    411 (32.3)          323 (25.4)   295 (23.2)   243 (19.1)   
   Unknown                  19 (37.3)           15 (29.4)    11 (21.6)    6 (11.8)     

Table [3](#T3){ref-type="table"} shows the association between DII scores and risk for all UATC, and separately for head and neck, and esophageal cancer. A more pro-inflammatory diet was associated with an increased risk of UATC (OR~Q4vsQ1~: 1.96; 95% CI: 1.58--2.43; *P*-trend \< 0.001). This finding was essentially unchanged after adjusting for potential confounders (OR~Q4vsQ1~: 1.73, 1.37--2.20; *P*-trend \< 0.001). Similarly, an inflammatory diet was associated with increased risk of head and neck cancer even after adjustment of confounders (OR~Q4vsQ1~: 1.92; 1.42--2.59; *P*-trend \< 0.001). Adjusted OR~Q4vsQ1~ remained significant for esophageal cancer (1.71; 1.54--1.90); however, a linear trend was attenuated compared with UATC overall (*P*-trend 0.07). Table [4](#T4){ref-type="table"} shows results according to subsite in head and neck cancer. Among these, all but laryngeal cancers produced results consistent with overall UATC. Notably, nasopharyngeal cancer and hypopharyngeal cancer showed strong positive associations, even in second and third quartiles, compared with the lowest quartile.

###### Impact of DII and selected variables

                                  DII quartiles        Case/control   OR (95% CI)^a^      Adjusted OR (95% CI)^b^
  ------------------------------- -------------------- -------------- ------------------- -------------------------
  **Head and neck + Esophagus**                                                           
                                  1 (−4.31 -- −1.00)   174/771        1.00 (Reference)    1.00 (Reference)
                                  2 (−1.00 -- −0.11)   243/770        1.41 (1.13--1.76)   1.33 (1.04--1.69)
                                  3 (0.11--0.58)       278/770        1.62 (1.31--2.01)   1.39 (1.10--1.76)
                                  4 (0.58--2.02)       333/770        1.96 (1.58--2.43)   1.73 (1.37--2.20)
                                  ***P* for trend**                   \<0.001             \<0.001
  **Head and neck**                                                                       
                                  1 (−4.08 -- −1.13)   96/443         1.00 (Reference)    1.00 (Reference)
                                  2 (−1.13 -- −0.12)   129/447        1.35 (1.00--1.81)   1.33 (0.97--1.82)
                                  3 (−0.12 − 0.52)     168/449        1.76 (1.33--2.35)   1.57 (1.17--2.13)
                                  4 (0.52--1.99)       202/446        2.16 (1.63--2.87)   1.92 (1.42--2.59)
                                  ***P* for trend**                   \<0.001             \<0.001
  **Esophagus**                                                                           
                                  1 (−4.31 -- −1.03)   78/328         1.00 (Reference)    1.00 (Reference)
                                  2 (−1.03 -- −0.11)   114/323        1.50 (1.08--2.10)   1.11 (0.99--1.25)
                                  3 (0.11--0.57)       110/321        1.45 (1.04--2.02)   1.42 (1.29--1.57)
                                  4 (0.57--2.02)       131/324        1.72 (1.24--2.38)   1.71 (1.54--1.90)
                                  ***P* for trend**                   0.003               0.07

^a^Odds ratios were estimated by conditional logistic models not adjusted for any covariates.

^b^Odds ratios were estimated by conditional logistic models adjusted for smoking, ethanol consumption, flushing phenotype, teeth and occupation group.

###### Imapct of DII according to detailed subsites in head and neck cancer

  Head and neck                                                            
  -------------------- --------------------- -------- -------------------- --------------------
  **Oral cavity**      1 (−4.08 -- −1.13)    47/196   1.00 (Reference)     1.00 (Reference)
                       2 (−1.13 -- −0.12)    50/183   1.17 (0.74--1.84)    1.21 (0.75--1.96)
                       3 (−0.12--0.52)       62/205   1.32 (0.86--2.03)    1.25 (0.79--1.96)
                       4 (0.52--1.99)        96/178   2.42 (1.58--3.71)    2.38 (1.52--3.72)
                       ***P* for trend**              \<0.001              \<0.001
  **Nasopharynx**      1 (−4.08 -- −1.13)    4/37     1.00 (Reference)     1.00 (Reference)
                       2 (−1.13 -- −0.12)    12/36    3.24 (0.92--11.46)   5.71 (1.05--30.89)
                       3 (−0.12 -- 0.52)     17/35    4.88 (1.47--16.17)   7.78 (1.65--36.57)
                       4 (0.52 -- 1.99)      17/45    3.65 (1.10--12.11)   4.99 (1.14--21.79)
                       ***P* for trend**              0.05                 0.09
  **Oropharynx**       1 (−4.08 -- −1.13)    12/56    1.00 (Reference)     1.00 (Reference)
                       2 (--1.13 -- −0.12)   18/52    1.62 (0.69--3.80)    2.18 (0.82--5.83)
                       3 (−0.12 -- 0.52)     22/49    2.02 (0.92--4.42)    2.14 (0.87--5.24)
                       4 (0.52 -- 1.99)      20/57    1.63 (0.72--3.69)    1.71 (0.65--4.50)
                       ***P* for trend**              0.21                 0.27
  **Hypopharynx**      1 (−4.08 -- −1.13)    6/51     1.00 (Reference)     1.00 (Reference)
                       2 (−1.13 -- −0.12)    23/61    3.29 (1.24--8.71)    4.39 (1.36--14.11)
                       3 (−0.12 -- 0.52)     29/65    4.18 (1.55--11.26)   4.59 (1.45--14.51)
                       4 (0.52 -- 1.99)      22/63    3.03 (1.15--7.97)    4.05 (1.24--13.25)
                       ***P* for trend**              0.07                 0.04
  **Larynx**           1 (−4.08 -- −1.13)    18/56    1.00 (Reference)     1.00 (Reference)
                       2 (−1.13 -- −0.12)    15/78    0.63 (0.30--1.33)    0.39 (0.16--0.99)
                       3 (−0.12 -- 0.52)     30/62    1.53 (0.77--3.06)    1.02 (0.43--2.44)
                       4 (0.52 -- 1.99)      29/79    1.17 (0.59--2.33)    0.59 (0.25--1.38)
                       ***P* for trend**              0.21                 0.68
  **Salivary gland**   1 (−4.08 -- −1.13)    5/23     1.00 (Reference)     1.00 (Reference)
                       2 (−1.13 -- −0.12)    6/21     1.35 (0.38--4.88)    1.57 (0.37--6.63)
                       3 (−0.12 -- 0.52)     4/15     1.41 (0.32--6.16)    1.07 (0.19--5.97)
                       4 (0.52 -- 1.99)      8/13     5.42 (1.01--29.17)   2.91 (0.40--21.19)
                       ***P* for trend**              0.08                 0.13

^a^Odds ratios were estimated by conditional logistic models not adjusted for any covariates.

^b^Odds ratios were estimated by conditional logistic models adjusted for smoking, ethanol

consumption, flushing phenotype, teeth and occupation group.

Table [5](#T5){ref-type="table"} shows the adjusted ORs of UATC according to strata of selected confounders: age, sex, smoking, alcohol consumption, flushing phenotype, number of teeth, occupation group and their interactions. Although there is apparent variability in the impact of the association according to strata, positive associations between DII and UATC risk were consistently observed. We explored alternative analyses using the DII computed with alcohol included and confirmed that results were consistent with those based on the DII not including alcohol (data not shown).

###### Results for stratified analysis by selected variables

  Head and neck + Esophagus                                                                                                                             
  --------------------------- -------------- ------------------------------------ ------------------- ------------------- ------------------- --------- ---------
  **Sex**                     Male           134/538                              192/607             225/628             275/693             0.012     
                                             1.00 (Reference) 1.17 (0.88--1.55)   1.21 (0.92--1.59)   1.41 (1.08--1.85)                                 
                              Female         40/233                               51/163              53/142              58/77               \<0.001   \<0.001
                                             1.00 (Reference) 1.88 (1.13--3.13)   1.91 (1.15--3.15)   3.87 (2.22--6.75)                                 
  **Age**                     \<60           61/264                               89/312              113/383             188/395             0.001     
                                             1.00 (Reference) 1.07 (0.71--1.61)   1.16 (0.78--1.72)   1.78 (1.22--2.60)                                 
                              ≥60            113/507                              154/458             165/387             145/375             0.006     0.18
                                             1.00 (Reference) 1.52 (1.11--2.08)   1.67 (1.22--2.28)   1.54 (1.12--2.14)                                 
  **Smoking**                 Never          45/378                               48/279              45/254              63/224              \<0.001   
                                             1.00 (Reference) 1.74 (0.98--3.08)   1.91 (1.08--3.36)   3.03 (1.65--5.55)                                 
                              Ever           129/393                              194/490             233/516             269/543             0.007     0.021
                                             1.00 (Reference)                     1.22 (0.90--1.66)   1.37 (1.03--1.84)   1.48 (1.10--1.98)             
  **Alcohol**                 Never          37/26941/259                         58/244              63/247              \<0.001                       
  **consumption**                            1.00 (Reference)                     1.14 (0.61--2.13)   1.85 (1.02--3.34)   3.21 (1.68--6.14)             
                              Ever           137/502                              201/510             220/526             270/523             0.003     0.58
                                             1.00 (Reference)                     1.25 (0.93--1.68)   1.17 (0.88--1.56)   1.59 (1.20--2.12)             
  **Flushing**                Yes            79/383                               97/383              124/377             143/412             0.040     
  **phenotype**                              1.00 (Reference)                     1.09 (0.69--1.72)   1.56 (1.01--2.42)   1.46 (0.93--2.30)             
                              No             88/363                               137/368             140/378             179/346             0.005     0.67
                                             1.00 (Reference)                     1.49 (0.96--2.32)   1.05 (0.67--1.64)   2.05 (1.34--3.13)             
  **Teeth**                   0--8           48/121                               77/131              65/111              88/132              0.540     
                                             1.00 (Reference)                     2.11 (0.88--5.05)   1.40 (0.57--3.44)   1.62 (0.62--4.25)             
                              9--20          58/218                               68/208              89/231              94/222              0.460     0.49
                                             1.00 (Reference)                     0.87 (0.45--1.68)   1.00 (0.54--1.88)   1.22 (0.65--2.29)             
                              ≥21            68/424                               96/427              118/419             145/403             0.002     
                                             1.00 (Reference)                     1.20 (0.77--1.88)   1.44 (0.94--2.20)   1.86 (1.22--2.85)             
  **Occupation**              Blue collar    56/143                               89/191              99/230              137/277             0.410     
  **group**                                  1.00 (Reference)                     0.79 (0.39--1.59)   0.80 (0.41--1.54)   1.18 (0.61--2.26)             
                              White collar   38/198                               40/241              62/234              77/244              0.080     \<0.001
                                             1.00 (Reference)                     0.91 (0.39--2.13)   1.15 (0.54--2.48)   1.78 (0.82--3.86)             
                              Other          78/411                               112/323             113/295             114/243             0.005     
                                             1.00 (Reference)                     1.70 (1.11--2.60)   1.61 (1.06--2.46)   1.97 (1.27--3.08)             

^a^Odds ratios were estimated by conditional logistic models adjusted for smoking, ethanol consumption, flushing, phenotype, teeth and occupation group.

^b^Interactions were evaluated by likelihood ratio test between a model including a cross-product term between variables of interest and DII quartiles and a model without the term.

DISCUSSION {#s3}
==========

For the first time in a Japanese population, this case-control study examined the association between inflammatory potential of diet, as estimated by the DII, and risk of UATC for the first time in a Japanese population. We found consistently significant positive associations with UATC risk even after accounting for potential confounders. Results were consistent among head and neck cancer and esophageal cancer. We also found that the strength of the association with DII scores was heterogeneous across subsites in head and neck cancer: nasopharyngeal and hypopharyngeal cancer showed increased risk at even in DII quartiles 2 and 3. In contrast, laryngeal cancer showed no obvious association with DII.

Our overall findings are in accordance with previous reports showing that a pro-inflammatory diet, as indicated by higher DII scores, was associated with UATC risk \[[@R27]--[@R29], [@R42]--[@R44]\]. Our findings also are consistent with previous results showing that smoking and alcohol drinking are established risk factors for UATC and our finding is in consistent with former findings. Constituents in cigarette smoke constituents, particularly reactive oxidative substances (ROS), activate epithelial cell intracellular signaling cascades that lead to inflammatory gene activation (e.g., IL-8 and TNF-α), and the secretion of those inflammatory mediators promotes chronic immune cell recruitment and inflammation \[[@R45]\]. Similarly, chronic ethanol exposure also induces inflammation; ethanol toxicity is associated with the induction of NF-κB that results in the expression of inflammatory mediators including cytokines (TNF-α, IL-6 and IL-12), lipid mediators, inducible nitric oxide synthase (iNOS) and cyclooxigenase-2 (COX-2) \[[@R46]\]. Therefore, a significantly positive association between DII and UATC risk seems biologically plausible.

Interestingly, we observed marked impact of even minor increases in DII scores in increasing hypopharyngeal and nasopharyngeal cancer risk. Both sites are known to be associated with infections by human papilloma virus (HPV) \[[@R47]--[@R50]\] and Epstein-Barr virus (EBV) \[[@R51], [@R52]\], respectively. Inflammation caused by chronic infection is regarded as a major risk factors for various types of cancer, and underlying infections and inflammation are linked to 15--20% of all cancer deaths \[[@R53]\]. Immune response to pathogens that establish persistent infections is designed to promote host defense; however, it also can stimulate chronic inflammation and tumor growth \[[@R54]\]. HPV infection produces and releases several inflammatory cytokines from keratinocytes, their main target cell type; from skin fibroblasts; and form different components of the innate and adaptive immune response, including macrophages, natural killer cells and lymphocytes. On the other hand, infection of EBV results in the activation of STAT3 and NF-κB signal cascades in target epithelial cells, which induces increased expression of inflammatory cytokines including IL-6 and COX-2 \[[@R55]\]. Persistent infections with these viruses have been linked to chronic inflammation, an important factor for cancer development \[[@R56]\]. Taking these facts into consideration, our finding suggests that the pro-inflammatory potential of diet, as indicated by higher DII scores, significantly increases risk of infection-related cancers.

Previous reports revealed protective effect of vegetable, fruits \[[@R57], [@R58]\], olive oil \[[@R59]\], fish \[[@R29], [@R60]\], whole grains \[[@R61], [@R62]\], vitamin \[[@R63], [@R64]\], folate \[[@R65], [@R66]\] and fiber \[[@R63], [@R67]\]; whereas there appears to be a carcinogenic effect of red and processed meat \[[@R68], [@R69]\], fat \[[@R58], [@R70]\] and carbohydrate \[[@R71], [@R72]\] for UATC. These foods and nutrients, all components of DII, have the potential to induce the inflammatory response by influencing inflammatory markers such as CRP, IL-1β, IL-4, IL-6, IL-10 and TNF-α \[[@R12], [@R13], [@R73]\]. Particularly, CRP, IL-6 and TNF-α, in particular, have been reported to be associated with a variety of cancers \[[@R74]--[@R78]\]. Cyclooxygenase pathway products with the potential to influence inflammation include reactive oxygen species (ROS) and nitric oxide (NO). These can damage DNA and other cellular macromolecules. This damage results in increased proliferation, mutations, DNA damage and angiogenesis \[[@R75], [@R79], [@R80]\]. Among inflammatory markers, IL-1βhas been demonstrated to induce the production of gelatinases, which are family members of the matrix metalloproteinases (MMPs) that contribute to tumor invasion and metastasis \[[@R81]\], whereas IL-4 and IL-10 play a role in immune suppression, and IL-6 plays a role in anti-apoptosis \[[@R74]\] for head and neck cancer.

The methodological strengths of this study include its large sample size with very high (96.7%) response rate. Second, the FFQ that provided the data for DII estimation was tested for validity and reproducibility \[[@R39], [@R82]\]. Third, potential confounding by age, sex and other factors was addressed by matching and statistical adjustment.

Despite its strengths, potential limitations of our study also warrant mention. First, we collected information about confounders via self-reported questionnaire, therefore, it is difficult to rule out potential sources of information bias. If present, however, the effect of such misclassification in relation to possible under-adjustment would be limited. Also consistency of results across stratified analysis by several potential confounders is reassuring. Second, the control participants were selected among non-cancer patients at our hospital. Because cases and controls were selected from the same hospital and almost all patients lived in the Tokai area of central Japan, the internal validity of this case--control study is likely to be acceptable \[[@R83]\].

Third, by not setting eligibility criteria for control diseases it is possible that certain specific diagnostic groups may be related exposures of interest. Fourth, the limited number of cases for particular subsites reduces statistical power. Fifth, because of the retrospective nature of data collection, information bias in responses to the FFQ cannot be ruled out. Sixth, no validation study on the DII has been conducted in Japan. However, the DII was designed for universal applicability and has been construct validated in numerous populations including Asian countries such as Korea \[[@R84]\] and Iran \[[@R85]\]. All of these validation studies produced essentially identical results. Seventh, 22 food parameters were not-available to calculate DII scores. Previously, we showed that DII scores calculated from fewer than 22 food parameters were associated with inflammation \[[@R86]\]. Some of the food parameters that are missing include ginger, turmeric, saffron, thyme, eugenol -- all of which are not consumed in high amounts in this population. However, presence of some missing parameters, such as various flavonoids, which are consumed regularly, could have influenced the results.

In conclusion, we found a positive association between intake of a pro-inflammatory diet, as indicated by high DII score, and risk of UATC in Japanese adults. Results persisted after adjusting for potential confounders, including smoking and drinking. The association was consistently observed in esophageal cancer and most of UATC subsites, except laryngeal cancer. The fact that subsites which are known to have an etiological association with persistent infection; i.e., nasopharyngeal and hypopharyngeal cancers, showed stronger associations. These results warrant further evaluation in future studies.

MATERIALS AND METHODS {#s4}
=====================

Subjects {#s4_1}
--------

This case-control study includes 1,028 incident UATC cases and 3,081 age- and sex-matched controls. Both cases and controls were selected from participants of the Hospital-based Epidemiologic Research Program at Aichi Cancer Center (HERPACC) between January 2001 and November 2005 at Aichi Cancer Center Hospital (ACCH) in Japan. Detail of HERPACC is described elsewhere \[[@R37]\]. Briefly, all first-visit outpatients (*n* = 29,736) during the study period were asked to complete self-administered questionnaire and provide blood samples. Of these, 28,776 (96.7%) agreed to participate and provided written informed consent. Of these, 14,329 subjects were not diagnosed as having cancer within the 1-year period before determining study eligibility. Among the remaining 14,447 subjects, 9,838 were diagnosed with incident cancer of any organ, 3,657 were prevalent cases and 952 were of undetermined status. Cases were selected from 9,838 incident cancer cases and controls from 14,329 participants who were determined not to have cancer.

Cases in this study were participants of HERPACC who were histologically diagnosed as having a newly incident UATC \[cancer of head and neck in 595 (57.9%), cancer of esophagus in 433 (42.1%)\] without any prior history of cancer. We defined UATC according to the following codes of the International Classification of Diseases and Related Health Problems (ICD10): cancers of the oral cavity and oropharynx (C00.3-C00.9, C01, C02.0-C02.4, C03, C04, C05.0-C05.2, C06, C09 and C10), hypopharynx (C12 and C13), oral cavity--oropharynx--hypopharynx if not otherwise specified (C02.8, C02.9, C05.8, C05.9 and C14), salivary glands (C07 and C08), nasopharynx (C11), larynx (C32) and esophagus (C15). Head and neck cancer was defined as UATC other than esophageal cancer. All subsites of UATC were frequency-matched on age and sex at a case-control ratio of 1:3.

Control subjects also were participants of HERPACC during the same period, but were confirmed to have no detectable cancer and no history of neoplasia. Non-cancer status was confirmed by medical examinations, including radiographic examinations when indicated. We applied individual matching for control selection on age (± 4 years)- and sex. They were selected randomly from non-cancer subjects among HERPACC participants in a case-control ratio of 1:3. The study was approved by the Institutional Ethics Committee at ACC.

Data collection {#s4_2}
---------------

Information on potential confounders, alcohol consumption, cumulative exposure to smoking, socioeconomic status (SES), number of teeth and flushing response after drinking of a glass of beer was collected using a self-administered questionnaire.

We grouped cumulative exposure to smoking status into four categories by pack-years (PY) as follows: nonsmoker, low-moderate smoker (PY\<20), high-moderate smoker (20≤PY\<40), and heavy smoker (PY ≥40). Daily alcohol consumption of various common beverages (Japanese *sake*, beer, *shochu*, whiskey and wine) was determined according to the average number of drinks per day, which was then converted into a Japanese *sake* (rice wine) equivalent measure of 180 ml; termed a *go*, which is a standard measure in Japan containing 23 g of ethanol. Drinking status in this study was classified into the four categories of never drinker, moderate drinker (less than 1 *go* on 5 days per week), high-moderate drinkers (1--2 *go* on 5 days per week) and heavy drinkers (more than 2 *go* on 5 days per week).

The intake of nutrients was measured using a semi-quantitative food frequency questionnaire (FFQ), described in detail elsewhere \[[@R38]\]. Briefly, the FFQ consisted of 47 single food items with eight frequency categories and three portion size categories (small, medium, and large) provided. We estimated average daily intake by multiplying the reported frequency of intake by the selected serving size of each food (g). Intakes of all food items were not-energy-adjusted. The FFQ was validated in a population similar to that of our study using a 3-day weighed dietary record as the reference standard; results indicated acceptable reproducibility and validity \[[@R39]\].

Participants also were asked about their occupation as a measure of SES and were categorized into three groups as follows: white collar, blue collar or others, including part-time employees, housewives, students, unemployed, retired and inactive. Number of teeth of participants were categorized into four groups as follows: 0, 1--8, 9--20, \>21. Flushing response after drinking of a glass of beer was categorized as yes or no.

Dietary inflammatory index {#s4_3}
--------------------------

Dietary inflammatory index (DII^®^) scores were estimated based on self-reported macro- and micronutrients (energy, protein, fat, carbohydrate, total dietary fiber, cholesterol, saturated fatty acid, monounsaturated fatty acid, polyunsaturated fatty acid, n-3 polyunsaturated fatty acid, n-6 polyunsaturated fatty acid, carotene, vitamin B1, vitamin B2, vitamin B6, vitamin B12, vitamin C, vitamin D, vitamin E, retinoic acid, folate, and iron) based on the FFQ, described in detail elsewhere \[[@R38]\]. Briefly, dietary data were first linked to a regionally representative global database that provided a robust estimate of the mean and the standard deviation for each food parameter included in the DII. These parameters then became the multipliers to express an individual's exposure relative to the "standard global mean" as a z-score. This was achieved by subtracting the "standard global mean" from the amount reported and dividing this value by the standard deviation. To minimize the effect of "right skewing," this value was then converted to a centered (on zero) proportion by converting the z-score to a proportion (i.e., with values from 0 to 1) then multiplying by 2 and subtracting 1. The centered proportion score for each food parameter for each subject was then multiplied by the corresponding food parameter effect score in order to obtain a food parameter-specific DII score. All of the food parameter-specific DII scores were then summed to create the overall DII score for each subject. Alcohol was not included in the DII calculation, as it was adjusted separately in the analyses. The remaining 23 food parameters that were not used or were missing are mentioned in [Supplementary Table 1](#SD1){ref-type="supplementary-material"}.

Statistical analyses {#s4_4}
--------------------

We evaluated the association between DII and UATC risk using quartiles of DII scores. Quartile thresholds for DII were based on the distribution of DII in matched controls. Odds ratios (ORs) and 95% confidence intervals (CI) were estimated using conditional logistic regression models, with the first DII quartile (Q1, most anti-inflammatory diet category) as the reference. In the logistic regression model, the linear association with DII was evaluated by including DII quartile as an ordinal score (1, 2, 3, and 4). Potential confounders considered in the adjusted analyses were smoking, alcohol consumption, flushing phenotype \[[@R40]\], number of teeth \[[@R41]\] and occupational group. We also examined the impact of DII according to anatomic subtypes of UATC. The impact of DII was evaluated with stratification by the above-mentioned confounders in UATC. Interactions were evaluated by the likelihood ratio test comparing a model including a cross-product term between variables of interest and DII quartiles and a model without the term.

Chi-square tests for categorical variables and ANOVA for continuous variables were used to assess difference across groups. Statistical analyses were performed using STATA^®^ SE version 13.1 (Stata Corporation, College Station, TX,

USA). *P*-Values less than 0.05 were considered significant.

SUPPLEMENTARY MATERIALS TABLES {#s5}
==============================

This study was supported by Grants-in-Aid for Scientific Research on Priority Areas from the Ministry of Education, Science, Sports, Culture and Technology of Japan (17015018 and 26860430), JSPS Kakenhi (18K10037), and a Grant-in-Aid for the Third Term Comprehensive 10-year Strategy for Cancer Control from the Ministry of Health, Labour and Welfare of Japan; and the National Cancer Center Research and Development Fund. (27-A-4).

Drs. Shivappa and Hébert were supported by grant number R44DK103377 from the United States National Institute of Diabetes and Digestive and Kidney Diseases.

NS, JRH, and KM contributed conception, design of the work. MA, NS, and KM conducted analyses. HI, IO, TA, YA, YH, NS, JRH and KM contributed to acquisition of data in the work. MA, NS, HI, IO, TA, YA, YH, CK, MN, YO, JRH and KM contributed to interpretation of data in the work. All authors participated in drafting and revising the manuscript and approved the version submitted. Each author accepts accountability for all aspects of the work.

**CONFLICTS OF INTEREST**

Dr. James R. Hébert owns controlling interest in Connecting Health Innovations LLC (CHI), a company planning to license the right to his invention of the dietary inflammatory index (DII) from the University of South Carolina in order to develop computer and smart phone applications for patient counselling and dietary intervention in clinical settings. Dr. Nitin Shivappa is an employee of CHI.
